Investigation of Exhaled Breath Samples from Patients with Alzheimer’s Disease Using Gas Chromatography-Mass Spectrometry and an Exhaled Breath Sensor System

Exhaled breath is a body secretion, and the sampling process of this is simple and cost effective. It can be non-invasively collected for diagnostic procedures. Variations in the chemical composition of exhaled breath resulting from gaseous exchange in the extensive capillary network of the body are proposed to be associated with pathophysiological changes. In light of the foreseeable potential of exhaled breath as a diagnostic specimen, we used gas chromatography and mass spectrometry (GC-MS) to study the chemical compounds present in exhaled breath samples from patients with Alzheimer’s disease (AD), Parkinson’s disease (PD), and from healthy individuals as a control group. In addition, we also designed and developed a chemical-based exhaled breath sensor system to examine the distribution pattern in the patient and control groups. The results of our study showed that several chemical compounds, such as 1-phenantherol and ethyl 3-cyano-2,3-bis (2,5,-dimethyl-3-thienyl)-acrylate, had a higher percentage area in the AD group than in the PD and control groups. These results may indicate an association of these chemical components in exhaled breath with the progression of disease. In addition, in-house fabricated exhaled breath sensor systems, containing several types of gas sensors, showed significant differences in terms of the normalized response of the sensitivity characteristics between the patient and control groups. A subsequent clustering analysis was able to distinguish between the AD patients, PD patients, and healthy individuals using principal component analysis, Sammon’s mapping, and a combination of both methods, in particular when using the exhaled breath sensor array system A consisting of eight sensors. With this in mind, the exhaled breath sensor system could provide alternative option for diagnosis and be applied as a useful, effective tool for the screening and diagnosis of AD in the near future.

[1]  R. Beninger,et al.  Nucleus basalis lesions: Implication of basoamygdaloid cholinergic pathways in memory , 1995, Brain Research Bulletin.

[2]  Jennifer L Madeo,et al.  The Role of Oxidative Stress in Alzheimer's Disease , 2013 .

[3]  P. Galassetti,et al.  Monitoring states of altered carbohydrate metabolism via breath analysis: are times ripe for transition from potential to reality? , 2013, Current opinion in clinical nutrition and metabolic care.

[4]  J. Huh,et al.  Exhaled Breath Analysis of Lung Cancer Patients Using Metal Oxide Sensor , 2011, 2011 First ACIS/JNU International Conference on Computers, Networks, Systems and Industrial Engineering.

[5]  Berlyne Gm,et al.  Silicon metabolism. II. Renal handling in chronic renal failure patients. , 1986 .

[6]  H. Haick,et al.  Detection of Alzheimer's and Parkinson's disease from exhaled breath using nanomaterial-based sensors. , 2013, Nanomedicine.

[7]  Xia Zhang,et al.  Role of oxidative stress in Alzheimer's disease , 2016, Biomedical reports.

[8]  George Perry,et al.  Oxidative stress and neurotoxicity. , 2008, Chemical research in toxicology.

[9]  James A. Covington,et al.  A Novel Tool for Noninvasive Diagnosis and Tracking of Patients with Inflammatory Bowel Disease , 2013, Inflammatory bowel diseases.

[10]  J. Câmara,et al.  Breath Analysis as a Potential and Non-Invasive Frontier in Disease Diagnosis: An Overview , 2015, Metabolites.

[11]  H. Haick,et al.  Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors , 2010, British Journal of Cancer.

[12]  Bogusław Buszewski,et al.  Human exhaled air analytics: biomarkers of diseases. , 2007, Biomedical chromatography : BMC.

[13]  K. Kantardjieff,et al.  Dialkyl phenyl phosphates as novel selective inhibitors of butyrylcholinesterase. , 2007, Biochemical and biophysical research communications.

[14]  M. Aschner,et al.  Metals, oxidative stress and neurodegeneration: A focus on iron, manganese and mercury , 2013, Neurochemistry International.

[15]  J. E. Rubin,et al.  Silicon metabolism: the basic facts in renal failure. , 1985, Kidney international. Supplement.

[16]  H. Byun,et al.  Analysis of diabetic patient's breath with conducting polymer sensor array , 2005 .

[17]  M P van der Schee,et al.  External validation of exhaled breath profiling using an electronic nose in the discrimination of asthma with fixed airways obstruction and chronic obstructive pulmonary disease , 2011, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[18]  A. Boner,et al.  Markers of oxidative stress are increased in exhaled breath condensates of children with atopic dermatitis , 2012, The British journal of dermatology.

[19]  V. Ferraris.  What do dogs, ancient Romans, Linus Pauling, and mass spectrometry have in common? Early lung cancer and exhaled breath. , 2016, The Journal of thoracic and cardiovascular surgery.

[20]  Ki-Hyun Kim,et al.  A review of breath analysis for diagnosis of human health , 2012 .

[21]  U. Erkorkmaz,et al.  Oxidative Stress Levels in Exhaled Breath Condensate Associated With COPD and Smoking , 2012, Respiratory Care.

[22]  Hossam Haick,et al.  Assessment, origin, and implementation of breath volatile cancer markers. , 2014, Chemical Society reviews.

[23]  J. Gmiński,et al.  Silicon metabolism , 1992, Biological Trace Element Research.

[24]  W. Miekisch,et al.  Diagnostic potential of breath analysis--focus on volatile organic compounds. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[25]  G. Berlyne,et al.  Silicon metabolism. I. Some aspects of renal silicon handling in normal man. , 1986, Nephron.

[26]  Trinad Chakraborty,et al.  Clinical Application of Volatile Organic Compound Analysis for Detecting Infectious Diseases , 2013, Clinical Microbiology Reviews.

[27]  E. Duysen,et al.  Induction of plasma acetylcholinesterase activity in mice challenged with organophosphorus poisons. , 2011, Toxicology and applied pharmacology.

[28]  M. J. Kim,et al.  Ameliorative effect of 1,2-benzenedicarboxylic acid dinonyl ester against amyloid beta peptide-induced neurotoxicity , 2009, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[29]  P. Babu,et al.  Polycyclic aromatic hydrocarbons in air and their neurotoxic potency in association with oxidative stress: A brief perspective , 2009 .

[30]  Ashley I. Bush,et al.  Metal dyshomeostasis and oxidative stress in Alzheimer’s disease , 2013, Neurochemistry International.

[31]  Ju-chan Kang,et al.  Effect of phenanthrene on haematological parameters in olive flounder, Paralichthys olivaceus (Temminch et Schlegel) , 2004 .

[32]  Krishna C. Persaud,et al.  Wound‐State Monitoring for Burn Patients Using E‐Nose/SPME System , 2010 .

[33]  Y. Duan,et al.  Diagnosis of breast cancer based on breath analysis: an emerging method. , 2013, Critical reviews in oncology/hematology.

[34]  David Smith,et al.  Breath analysis: the approach towards clinical applications. , 2007, Mini reviews in medicinal chemistry.

[35]  S. M. Khaffaf,et al.  Application of unsupervised clustering methods to the assessment of malodour in agriculture using an array of conducting polymer odour sensors , 1997 .